Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial

Authors not listed

RWTH Aachen University · 2020

Dysbiosis Human Randomized controlled trial

Abstract

The primary research question: In critically ill patients with nutrition 'risk factors', what is the effect of providing combined EN/PN to the group prescribed a higher dose (≥2.2 grams/kg/day) of protein/amino acid administration compared to a low group prescribed ≤1.2 gram/kg/day (EN only) on patient's functional recovery as measured by 6-minute walk distance just prior to hospital discharge? The hypothesis: Compared to a control group reflective of usual care prescribing practices and an EN only approach, the administration of a higher dose protein/amino acids using EN and PN to nutritionally high-risk critically ill patients will be associated with improved functional outcome.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-22 MST

Cite this

APA

Anonymous. (2020). The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial. <em>RWTH Aachen University</em>. https://clinicaltrials.gov/study/NCT04012333

Vancouver

Anonymous. The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial. RWTH Aachen University. 2020.

BibTeX

@misc{anon2020TheEff, title = {The Effect of Higher Protein Dosing in Critically Ill Patients: A Multicenter Randomized Trial}, author = {Anonymous}, journal = {RWTH Aachen University}, year = {2020}, }